Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001810417-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 3, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
15,959
Total Value
$270,593.02
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Apr 1, 2026 | Sale | 500 | $15.86 | $7,929.00 | 32,797 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 1, 2026 | Sale | 7,479 | $16.83 | $125,840.91 | 25,318 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 2, 2026 | Sale | 6,200 | $17.02 | $105,553.14 | 19,118 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 2, 2026 | Sale | 1,780 | $17.57 | $31,269.97 | 17,338 | Direct | โ | View Details |